Applying the net-benefit framework for analyzing and presenting cost-effectiveness analysis of a maternal and newborn health intervention

PLoS ONE

Volumn 7, Issue 7, 2012, Pages

  Hounton, Sennen ^a,b   Newlands, David ^b  

^a CENTRE MURAZ   (Burkina Faso)

^b UNIVERSITY OF ABERDEEN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BIRTH; CHILD HEALTH; COST EFFECTIVENESS ANALYSIS; DELIVERY; EDUCATION; FEMALE; HEALTH CARE FACILITY; HEALTH CARE POLICY; HEALTH CENTER; HEALTH SURVEY; HOUSEHOLD; HUMAN; MATERNAL NEWBORN HEALTH; MATERNAL WELFARE; MATHEMATICAL ANALYSIS; NET BENEFIT FRAMEWORK; NEWBORN; ORGANIZATION AND MANAGEMENT; PERINATAL MORTALITY; PREGNANCY; PROBABILITY; RETROSPECTIVE STUDY; RISK ASSESSMENT; SKILL;

COST-BENEFIT ANALYSIS; FEMALE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INFANT WELFARE; INFANT, NEWBORN; MATERNAL WELFARE; PREGNANCY;

EID: 84864059853     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0040995     Document Type: Article

References (20)

1. Ronsmans C, Graham WJ, (2006) Lancet Maternal Survival Series steering group: Maternal mortality: who, when, where, and why. Lancet, 368 (9542): 1189-200.
2. Hounton S, Chapman G, Menten J, De Brouwere V, Ensor T, et al. (2008) Accessibility and utilisation of maternity care within a Skilled Care Initiative in rural Burkina Faso. Tropical Medicine and International Health, 13: Suppl 1, p 44-52.
3. Hounton S, Byass P, Bassane B, (2009) Towards maternal and perinatal mortality reduction in rural Burkina Faso: community are not empty vessels. Global Health Action 7: 2.
4. Drummond MF, Sclpher MJ, Torrance GW, O'Brien BJ, Stoddart GL, (2005) Methods for the economic evaluation of health care programmes. Oxford University Press, 3rd Ed, New York 396 p.
5. Adam T, Lim SS, Mehta S, Bhutta ZA, Fogstad H, et al. (2005) Cost effectiveness analysis of strategies for maternal and neonatal health in developing countries. BMJ, 12 331(7525): 1107.
6. Edejer TT, Aikins M, Black R, Wolfson L, Hutubessy R, et al. (2005) Cost effectiveness analysis of strategies for child health in developing countries. BMJ, 331 (7526): 1177.
7. Hogan DR, Baltussen R, Hayashi C, Lauer JA, Salomon JA, (2005) Cost effectiveness of strategies to combat HIV/ AIDS in developing countries. BMJ 331(7530): 1431-7.
8. Briggs A, Fenn P, (1998) Confidence intervals or surfaces? Uncertainty of the cost-effectiveness plane. Health Econ 7: 723-740.
9. Briggs AH, Gray AM, (1999) Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess, 3.
10. Ternent L, McNamee P, Newlands D, Belemsaga D, Gbangou A, et al. (2010) Willingness to pay for maternal health outcomes: are women willing to pay more than men? Appl Health Econ Health Policy, 8 (2): 99-109.
11. Stinnett AA, Mullahy J, (1998) Net health benefits: a new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making, 18(2 suppl) pp. S68-80.
12. Hoch JS, Briggs AH, William AR, (2002) Something old, something new, something borrowed, something blue: a framework for the marriage of health econometrics and cost-effectiveness analysis. Health Econ 11: 415-430.
13. Hoch JS, Rockx MA, Krahn AD, (2006) Using net-benefit regression framework to construct cost-effectiveness acceptability curves: an example using data from a trial of external loop recorders versus Holter monitoring for ambulatory monitoring of "community acquired" syncope. BMC Health Services Research 6: 68.
14. Newnlands D, Yugbare-Belemsaga D, Ternent L, Hounton S, Chapman G, (2008) Assessing the costs and cost-effectiveness of a Skilled Care Initiative in rural Burkina Faso. Tropical Medicine and International Health 13(1): 61-67.
15. Hoch JS, Dewa CS, (2007) Lessons from trial-based cost-effectiveness analysis of mental health interventions. Why uncertainty about outcomes, estimates and willingness-to-pay matters. Pharmacoecnomics, 25 (10): 807-816.
16. Hoch JS, Blume JD, (2008) Measuring and illustrating statistical evidence in a cost-effectiveness analysis. Journal of Health Economics 27: 476-495.
17. Claxton K, (1999) The irrelevance of inference: a decision making framework to the stochastic evaluation of health care technologies. J Health Econom 18: 341-364.
18. Fenwick E, Claxton K, Sculpher M, (2001) Representing uncertainty: the role of cost-effectiveness acceptability curves. Health Econ 10: 779-787.
19. Filmer D, Pritchett LH, (2001) Estimating wealth effects without expenditure data-or tears: an application to educational enrollments in states of India. Demography 38(1): 115-32.
20. Victora CG, Black RE, Boerma JT, Bryce J, (2011) Measuring impact in the Millennium Development Goal era and beyond: a new framework to large-scale effectiveness evaluations. Lancet, 1 377(9759): 85-95.